V8 Peptides — Engineered Performance
Research Library
Selank vs Semax: Readout-by-Readout Research Ledger
SelankComparison

Selank vs Semax: Readout-by-Readout Research Ledger

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How do Selank and Semax differ in published research? They share a Pro-Gly-Pro tail and an origin in the same Russian research program, but their reported readouts diverge. Selank, a tuftsin analog, is reported in enkephalin-degrading enzyme assays (IC50 about 15–20 µM), GABA-related gene-expression and binding work, and spleen immune-gene panels. Semax, an ACTH(4-7) analog, is reported in enzyme assays (IC50 about 10 µM) and in rat hippocampal and ischemic-cortex studies of BDNF, NGF and their receptors. This article lines the two up readout by readout and notes where no comparison exists. Supplied by V8 Peptides as lyophilized research vials, for laboratory research use only.

Most Selank versus Semax comparisons stay at the level of one-line descriptions. This one is a ledger: for each type of experiment, what was measured for each peptide, with the numbers and the preparation, and where one side of the comparison is empty. It is meant to help a researcher decide which peptide matches a given study question, or whether the literature supports a question at all. A broader narrative comparison is on the library page Selank versus Semax; background for each compound is in the Selank research guide and Semax research guide. For laboratory research use only.

Side-by-side specifications

SpecificationSelankSemax
SequenceThr-Lys-Pro-Arg-Pro-Gly-ProMet-Glu-His-Phe-Pro-Gly-Pro
ParentTuftsin (Thr-Lys-Pro-Arg)ACTH fragment, residues 4-7
Net charge characterBasic residues (Lys, Arg)Acidic and aromatic residues (Glu, His, Phe)
FormulaC33H57N11O9C37H51N9O10S
Product vial10 mg lyophilized15 mg lyophilized
Purity specification≥98% HPLC≥98% HPLC
UV chromophoreNo aromatic residue; peptide-bond absorbance onlyPhe and His add absorbance and retention behavior

The chemistry already predicts bench differences. Selank's Lys and Arg make it strongly basic and very hydrophilic; Semax's Met, Phe and His make it more hydrophobic on reversed-phase HPLC and give it an oxidation-prone sulfur. Neither point comes from a paper cited here; they follow from the sequences.

Readout ledger

ReadoutSelankSemax
Enkephalin-degrading enzymes (human serum)IC50 20 µM (reference 1)IC50 10 µM (reference 1)
Enkephalin hydrolysis in plasmaIC50 15 µM; more potent than bacitracin and puromycin in that assay (reference 2)Not reported in the cited abstract
Hippocampal BDNF / trkBIntranasal BDNF regulation reported in rat hippocampus (reference 3, title only)1.4-fold BDNF protein, 1.6-fold trkB phosphorylation after a single application at 50 µg/kg (reference 4)
Hippocampal transcriptome36 genes changed >2-fold after a single intranasal administration; 20 after a course (reference 5)Neurotrophin and receptor transcripts increased (references 4 and 6)
Ischemia modelNot in the cited abstractsSemax and PGP activated transcription of neurotrophins and receptors in rat cortex after artery occlusion (reference 6)
GABAergic genes45 genes at 1 h, 22 at 3 h in rat frontal cortex (reference 7)Not in the cited abstracts
GABA bindingPositive allosteric modulation reported (reference 8)Not in the cited abstracts
Immune-gene expression34 of 84 inflammation genes changed in mouse spleen (reference 9)Not in the cited abstracts

Reading the table: only one assay, the serum enkephalinase assay, has numbers for both peptides from the same study, and that comparison puts them within a factor of two of each other. Every other row is one-sided. Statements that one peptide is "stronger" or "more neurotrophic" than the other have no direct support in these abstracts.

Where the two overlap

The shared tail is the likely reason for overlap. Pro-Gly-Pro is also studied by itself: in the rat ischemia work, the tripeptide activated neurotrophin transcription with a profile partly overlapping Semax's (reference 6), and a Pro-Gly-Pro transcriptome study in focal ischemia is also in the literature (reference 10, title only). In the human-serum assay, pentapeptide fragments of both heptapeptides inhibited the enzymes while shorter and longer fragments did not (reference 1). Experimentally, that makes the tail a reasonable control: a Pro-Gly-Pro-only or fragment arm can show whether a readout belongs to the shared tail or to the distinct head. For combination experiments, see the factorial layout in the library's stack discussion for these two peptides.

Where they diverge

The heads differ in origin and in what the literature measured. Tuftsin, the Selank head, is a natural phagocytosis-stimulating peptide whose analogs have been reviewed across immunomodulatory, anti-inflammatory and antimicrobial studies (reference 11). Semax's head is an ACTH fragment, and its published rodent work centers on neurotrophin and trkB expression, with timing data: BDNF protein peaked at 1.4-fold, and the effect was framed as a modulation of the hippocampal BDNF/trkB system (reference 4). Selank's rodent work is split across GABA-related genes, immune genes and strain-dependent behavior, where effects were reported in BALB/c and not C57BL/6 mice (reference 12).

These differences affect model choice. A question about neurotrophin signaling has direct precedent with Semax in rat hippocampus; a question about GABA-related transcription has precedent with Selank in rat cortex; a question about splenic immune-gene expression has precedent with Selank in mouse. Where a question has no precedent for either peptide, regard it as exploratory.

Why cross-study comparisons mislead

Putting numbers from different papers side by side invites errors, and a ledger like this one should be read with four cautions. First, amounts were reported per kilogram of animal weight and differ between papers (50 µg/kg for the Semax hippocampal study, 100 to 300 µg/kg in the Selank reports), so effect sizes do not scale to one another. Second, the tissues and time points differ: one hour and three hours in cortex, single and course exposure in hippocampus, six and twenty-four hours in spleen. Third, methods differ: radioligand binding, qPCR panels, microarrays and slice electrophysiology answer different questions. Fourth, the laboratories and animal strains differ, and strain alone changed whether Selank had a behavioral effect in the mouse work (reference 12). A fair comparison is therefore only possible inside one experiment, with both peptides run in parallel, matched for lot documentation, vehicle, route, schedule and scorer blinding.

Handling differences at the bench

Both product pages state refrigeration at 2–8 °C, −20 °C for long-term holding, and protection from heat, moisture and light. Beyond that, the sequences suggest different cautions. Semax's methionine can oxidize, so limit solution time, avoid agitation that introduces oxygen, and consider an HPLC check on any stock kept for days. Selank has no Met, Cys or Trp and is chemically more robust, but its basic, hydrophilic character means it adsorbs readily to negatively charged surfaces at low concentration, so low-binding labware and fresh dilutions are sensible. Degradation pathways of this kind are reviewed in the general peptide-stability literature (reference 13).

Concentration arithmetic is identical for both: concentration (mg/mL) = vial mass (mg) ÷ diluent volume (mL). Use the reconstitution calculator and follow how to reconstitute a lyophilized peptide. For analysis, see Selank purity testing and Semax purity testing; lot data appear on the COA page where published.

Choosing between them for a study question

Study questionPrecedent in the cited literatureComment
Enkephalinase inhibition assayBothRun both in the same assay to obtain a direct comparison
Hippocampal BDNF/trkB responseSemax (protein and mRNA); Selank (title-level report)Time-course design from the Semax data
GABAergic gene-expression profileSelankInclude 1 h and 3 h time points
Inflammation-gene panelSelankInclude fragment controls
Ischemia-model transcriptionSemax and Pro-Gly-ProTail-only arm is informative
BehaviorSelank (strain-dependent)Choose strains deliberately

For sourcing, see where to buy Selank and where to buy Semax; the shop lists the range. All material is for laboratory research use only.

Frequently asked questions

What do Selank and Semax have in common?

Both are seven-residue peptides ending in Pro-Gly-Pro, and both come from the same Russian research tradition. In a human-serum assay both inhibited enkephalin-degrading enzymes.

What is the main structural difference?

Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, derived from tuftsin. Semax is Met-Glu-His-Phe-Pro-Gly-Pro, derived from an ACTH fragment.

Which has been studied for BDNF?

Semax has direct reports in rat hippocampus of increased BDNF protein and trkB phosphorylation. A Selank intranasal BDNF report exists, cited here by title only.

Which has been studied for GABA-related readouts?

Selank: gene-expression changes in rat frontal cortex and positive allosteric modulation of GABA binding in membranes.

Is there a head-to-head study?

Only for the serum enkephalin-degrading enzyme assay in the cited abstracts: IC50 10 µM for Semax and 20 µM for Selank. Other comparisons are one-sided.

Does one peptide outperform the other?

The abstracts cited here do not support that statement, because the readouts differ and few were run in the same study.

Why use a Pro-Gly-Pro-only control?

Because both peptides share the tail, and in a rat ischemia model the tripeptide partly reproduced Semax's transcription profile. A tail-only arm shows what the head adds.

Do they need different handling?

Semax contains methionine and is more oxidation-prone. Selank has no Met, Cys or Trp but adsorbs to surfaces at low concentration. Both are stored at 2–8 °C, or −20 °C for long-term holding.

How are stock concentrations calculated?

Vial mass in mg divided by diluent volume in mL gives mg/mL for either peptide. The calculator on the site converts units.

Is this a recommendation to use either peptide?

No. It summarizes preclinical literature for laboratory planning. Both are for laboratory research use only.

Related reading: Selank Storage and Stability: A Sequence-Based View, How Selank Is Made: Synthesis Steps and Impurities, Nootropic Peptides: Semax and Selank Evidence Map.

References

  1. Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, et al. [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorg Khim. 2001;27(3):180-3. PMID: 11443939
  2. Zozulya AA, Kost NV, Yu Sokolov O, Gabaeva MV, Grivennikov IA, Andreeva LN, et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bull Exp Biol Med. 2001;131(4):315-7. doi:10.1023/a:1017979514274
  3. Inozemtseva LS, Karpenko EA, Dolotov OV, Levitskaya NG, Kamensky AA, Andreeva LA, et al. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Dokl Biol Sci. 2008;421:241-3. doi:10.1134/s0012496608040066
  4. Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60. doi:10.1016/j.brainres.2006.07.108
  5. Kolomin TA, Agapova TIu, Agniullin IaV, Shram SI, Shadrina MI, Slominskiĭ PA, et al. [Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank]. Zh Vyssh Nerv Deiat Im I P Pavlova. 2013;63(3):365-74. PMID: 24450168
  6. Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol. 2010;30(1):71-9. doi:10.1007/s10571-009-9432-0
  7. Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol. 2016;7:31. doi:10.3389/fphar.2016.00031
  8. Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein Pept Lett. 2018;25(10):914-923. doi:10.2174/0929866525666180925144642
  9. Kolomin T, Shadrina M, Andreeva L, Slominsky P, Limborska S, Myasoedov N. Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. Regul Pept. 2011;170(1-3):18-23. doi:10.1016/j.regpep.2011.05.001
  10. Medvedeva EV, Dmitrieva VG, Povarova OV, Limborskaia SA, Skvortsova VI, Miasoedov NF, et al. [Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia]. Mol Biol (Mosk). 2014;48(2):277-87. PMID: 25850296
  11. Siebert A, Gensicka-Kowalewska M, Cholewinski G, Dzierzbicka K. Tuftsin - Properties and Analogs. Curr Med Chem. 2017;24(34):3711-3727. doi:10.2174/0929867324666170725140826
  12. Vasil'eva EV, Kondrakhin EA, Salimov RM, Kovalev GI. [COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.]. Eksp Klin Farmakol. 2016;79(9):3-11. PMID: 29787664
  13. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. doi:10.1007/s11095-009-0045-6

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.